{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T01:07:39Z","timestamp":1771549659814,"version":"3.50.1"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A2C1010766"],"award-info":[{"award-number":["NRF-2020R1A2C1010766"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2020R1A6A1A03044512"],"award-info":[{"award-number":["NRF-2020R1A6A1A03044512"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010097","name":"China Association for Science and Technology","doi-asserted-by":"publisher","award":["2017ZX09304027"],"award-info":[{"award-number":["2017ZX09304027"]}],"id":[{"id":"10.13039\/100010097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biomaterials.2021.121081","type":"journal-article","created":{"date-parts":[[2021,8,28]],"date-time":"2021-08-28T11:58:16Z","timestamp":1630151896000},"page":"121081","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Carrier-free micellar CpG interacting with cell membrane for enhanced immunological treatment of HIV-1"],"prefix":"10.1016","volume":"277","author":[{"given":"Haejoo","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juyoung","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Koung","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeol Kyo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunyoung","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9245-703X","authenticated-orcid":false,"given":"Mark","family":"Loznik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Hoon","family":"Huh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0480-1804","authenticated-orcid":false,"given":"Minseok","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-O","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/j.1600-065X.2008.00737.x","article-title":"Innate immunity to virus infection","volume":"227","author":"Takeuchi","year":"2009","journal-title":"Immunol. Rev."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121081_bib2","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"7","author":"Kawai","year":"2006","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121081_bib3","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.cyto.2008.07.009","article-title":"Innate immune response to viral infection","volume":"43","author":"Koyama","year":"2008","journal-title":"Cytokine"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121081_bib4","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0952-7915(00)00241-7","article-title":"NK cells and NKT cells in innate defense against viral infections","volume":"13","author":"Biron","year":"2001","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.coi.2004.11.001","article-title":"NK cells in innate immunity","volume":"17","author":"Hamerman","year":"2005","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121081_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1159\/000324176","article-title":"Natural killer cell responses to viral infection","volume":"3","author":"Brandstadter","year":"2011","journal-title":"J. Innate Immun."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121081_bib7","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.4049\/jimmunol.179.4.2642","article-title":"Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-Infected subjects undergoing antiretroviral treatment","volume":"179","author":"Chehimi","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121081_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/nri2935","article-title":"DCs and NK cells: critical effectors in the immune response to HIV-1","volume":"11","author":"Altfeld","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121081_bib9","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.4049\/jimmunol.173.12.7269","article-title":"Endogenous IFN-\u03b1 production by plasmacytoid dendritic cells exerts an antiviral effect on thymic HIV-1 infection","volume":"173","author":"Gurney","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121081_bib10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1084\/jem.20051395","article-title":"Production of type I interferons : plasmacytoid dendritic cells and beyond","volume":"202","author":"Asselin-Paturel","year":"2005","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121081_bib11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.immuni.2006.08.007","article-title":"Type I interferons in host defense","volume":"25","author":"Stetson","year":"2006","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121081_bib12","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.coviro.2011.10.026","article-title":"Type I interferons: diversity of sources, production pathways and effects on immune responses","volume":"1","author":"Swiecki","year":"2011","journal-title":"Curr. Opin. Virol."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.121081_bib13","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1189\/jlb.0306154","article-title":"Type I interferon production in HIV-infected patients","volume":"80","author":"Hosmalin","year":"2006","journal-title":"J. Leukoc. Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121081_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1086\/430931","article-title":"Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection","volume":"192","author":"Kamga","year":"2005","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11904-014-0244-6","article-title":"Type I interferon: understanding its role in HIV pathogenesis and therapy","volume":"12","author":"Bosinger","year":"2015","journal-title":"Curr. HIV AIDS Rep."},{"issue":"21","key":"10.1016\/j.biomaterials.2021.121081_bib16","doi-asserted-by":"crossref","first-page":"11175","DOI":"10.1128\/JVI.00753-09","article-title":"Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell function","volume":"83","author":"Conry","year":"2009","journal-title":"J. Virol."},{"issue":"Supplement_2","key":"10.1016\/j.biomaterials.2021.121081_bib17","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.1086\/655657","article-title":"Innate immune activation in primary HIV-1 infection","volume":"202","author":"Chang","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.biomaterials.2021.121081_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-1-4614-4433-6_3","article-title":"Plasmacytoid dendritic cells in HIV infection","volume":"762","author":"O'Brien","year":"2013","journal-title":"Adv. Exp. Med. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0952-7915(97)80152-5","article-title":"Innate immunity: impact on the adaptive immune response","volume":"9","author":"Medzhitov","year":"1997","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121081_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3390\/v3060920","article-title":"Pattern recognition receptors and the innate immune response to viral infection","volume":"3","author":"Thompson","year":"2011","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.biomaterials.2021.121081_bib21","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0952-7915(99)00048-5","article-title":"The role of CpG motifs in innate immunity","volume":"12","author":"Krieg","year":"2000","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0264-410X(98)00151-0","article-title":"CpG motifs as immune adjuvants","volume":"17","author":"Klinman","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121081_bib24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2174\/1566524023362159","article-title":"Toll-like receptor 9, CpG DNA and innate immunity","volume":"2","author":"Ali","year":"2002","journal-title":"Curr. Mol. Med."},{"issue":"7","key":"10.1016\/j.biomaterials.2021.121081_bib25","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1002\/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U","article-title":"Identification of CpG oligonucleotide sequences with high induction of IFN-\u03b1\/\u03b2 in plasmacytoid dendritic cells","volume":"31","author":"Krug","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121081_bib26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1189\/jlb.0509314","article-title":"Higher activation of TLR9 in plasmacytoid dendritic cells by microbial DNA compared with self-DNA based on CpG-specific recognition of phosphodiester DNA","volume":"86","author":"Coch","year":"2009","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","article-title":"Use of CpG oligodeoxynucleotides as immune adjuvants","volume":"199","author":"Klinman","year":"2004","journal-title":"Immunol. Rev."},{"issue":"45","key":"10.1016\/j.biomaterials.2021.121081_bib28","doi-asserted-by":"crossref","first-page":"5263","DOI":"10.1016\/j.vaccine.2005.06.024","article-title":"TLR agonists as vaccine adjuvants: comparison of CpG ODN and Resiquimod (R-848)","volume":"23","author":"Weeratna","year":"2005","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121081_bib29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2008.12.012","article-title":"CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases","volume":"61","author":"Klinman","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.uct.2007.11.003","article-title":"CpG oligodeoxynucleotides as immunotherapy in cancer","volume":"3","author":"Jahrsd\u00f6rfer","year":"2008","journal-title":"Update Canc. Therapeut."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121081_bib31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nri1329","article-title":"Immunotherapeutic uses of CpG oligodeoxynucleotides","volume":"4","author":"Klinman","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121081_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2165\/00126839-200809030-00001","article-title":"A Review of the role of CpG oligodeoxynucleotides as toll-like receptor 9 agonists in prophylactic and therapeutic vaccine development in infectious diseases","volume":"9","author":"Gupta","year":"2008","journal-title":"Drugs R"},{"issue":"22","key":"10.1016\/j.biomaterials.2021.121081_bib33","doi-asserted-by":"crossref","first-page":"12344","DOI":"10.1128\/JVI.78.22.12344-12354.2004","article-title":"CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo","volume":"78","author":"Schlaepfer","year":"2004","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121081_bib34","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1096\/fj.04-3185fje","article-title":"Enhanced HIV-1 specific immune response by CpG ODN and HIV-1 immunogen-pulsed dendritic cells confers protection in the Trimera murine model of HIV-1 infection","volume":"19","author":"Ayash-Rashkovsky","year":"2005","journal-title":"Faseb. J."},{"issue":"8","key":"10.1016\/j.biomaterials.2021.121081_bib35","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/aid.2012.0264","article-title":"methamphetamine inhibits toll-like receptor 9-mediated anti-HIV activity in macrophages","volume":"29","author":"Ping Cen","year":"2013","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121081_bib36","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1128\/JVI.00222-16","article-title":"A novel toll-like receptor 9 agonist, MGN1703, enhances HIV-1 transcription and NK cell-mediated inhibition of HIV-1-Infected autologous CD4+ T cells,","volume":"90","author":"Offersen","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.biomaterials.2021.121081_bib37","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature01406","article-title":"DNA in a material world","volume":"421","author":"Seeman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2021.121081_bib38","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nnano.2011.187","article-title":"Challenges and opportunities for structural DNA nanotechnology","volume":"6","author":"Pinheiro","year":"2011","journal-title":"Nat. Nanotechnol."},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121081_bib39","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1039\/c1cs90048j","article-title":"DNA in a modern world","volume":"40","author":"Stulz","year":"2011","journal-title":"Chem. Soc. Rev."},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121081_bib40","doi-asserted-by":"crossref","first-page":"5636","DOI":"10.1039\/c1cs15057j","article-title":"DNA origami: a quantum leap for self-assembly of complex structures","volume":"40","author":"T\u00f8rring","year":"2011","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2021.121081_bib41","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.sbi.2014.07.010","article-title":"Designer three-dimensional DNA architectures","volume":"27","author":"Ke","year":"2014","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.biomaterials.2021.121081_bib42","doi-asserted-by":"crossref","first-page":"17068","DOI":"10.1038\/natrevmats.2017.68","article-title":"DNA nanotechnology","volume":"3","author":"Seeman","year":"2017","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2217\/nnm-2017-0143","article-title":"Functional nanocarrier for drug and gene delivery via local administration in mucosal tissues","volume":"13","author":"Wang","year":"2018","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biomaterials.2021.121081_bib44","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/nnano.2012.73","article-title":"Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery","volume":"7","author":"Lee","year":"2012","journal-title":"Nat. Nanotechnol."},{"issue":"5","key":"10.1016\/j.biomaterials.2021.121081_bib45","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/adma.200700866","article-title":"DNA block copolymer micelles \u2013 a combinatorial tool for cancer nanotechnology","volume":"20","author":"Alemdaroglu","year":"2008","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.biomaterials.2021.121081_bib46","first-page":"2010","article-title":"Drug delivery by a self-assembled DNA tetrahedron for overcoming drug resistance in breast cancer cells, Chem","volume":"49","author":"Kim","year":"2013","journal-title":"Commun. Now."},{"issue":"43","key":"10.1016\/j.biomaterials.2021.121081_bib47","doi-asserted-by":"crossref","first-page":"12852","DOI":"10.1002\/chem.201001816","article-title":"Tunable hydrophobicity in DNA micelles: design, synthesis, and characterization of a new family of DNA amphiphiles","volume":"16","author":"Anaya","year":"2010","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.biomaterials.2021.121081_bib48","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.biomaterials.2016.11.020","article-title":"Modular delivery of CpG-incorporated lipid-DNA nanoparticles for spleen DC activation","volume":"115","author":"Jin","year":"2017","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121081_bib49","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1021\/acsbiomaterials.7b00440","article-title":"Administration of soft matter lipid-DNA nanoparticle as the immunostimulant via multiple routes of injection in vivo","volume":"3","author":"Jin","year":"2017","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.biomaterials.2021.121081_bib50","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2019.09.013","article-title":"Soft matter DNA nanoparticles hybridized with CpG motifs and peptide nucleic acids enable immunological treatment of cancer","volume":"315","author":"Jin","year":"2019","journal-title":"J. Contr. Release"},{"issue":"9","key":"10.1016\/j.biomaterials.2021.121081_bib51","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.4049\/jimmunol.170.9.4465","article-title":"Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells","volume":"170","author":"Kerkmann","year":"2003","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.biomaterials.2021.121081_bib52","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.4049\/jimmunol.173.7.4433","article-title":"Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells","volume":"173","author":"Moseman","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121081_bib53","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.4049\/jimmunol.179.4.2097","article-title":"NK cell lysis of HIV-1-Infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells","volume":"179","author":"Tomescu","year":"2007","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121081_bib54","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1021\/ct700301q","article-title":"Gromacs 4: algorithms for highly efficient, load-balanced, and scalable molecular simulation","volume":"4","author":"Hess","year":"2008","journal-title":"J. Chem. Theor. Comput."},{"issue":"8","key":"10.1016\/j.biomaterials.2021.121081_bib55","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1021\/acs.jctc.5b00286","article-title":"Martini coarse-grained force field: extension to DNA","volume":"11","author":"Uusitalo","year":"2015","journal-title":"J. Chem. Theor. Comput."},{"issue":"42","key":"10.1016\/j.biomaterials.2021.121081_bib56","doi-asserted-by":"crossref","first-page":"13130","DOI":"10.1039\/C9TC03204E","article-title":"Hyperconjugation-induced chromism in linear responsive polymers","volume":"7","author":"Choi","year":"2019","journal-title":"J. Mater. Chem. C"},{"issue":"23","key":"10.1016\/j.biomaterials.2021.121081_bib57","doi-asserted-by":"crossref","first-page":"7830","DOI":"10.1021\/jp101759q","article-title":"Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types","volume":"114","author":"Klauda","year":"2010","journal-title":"J. Phys. Chem. B"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib58","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/ct200723y","article-title":"Optimization of the CHARMM additive force field for DNA: improved treatment of the BI\/BII conformational equilibrium","volume":"8","author":"Hart","year":"2012","journal-title":"J. Chem. Theor. Comput."},{"issue":"10","key":"10.1016\/j.biomaterials.2021.121081_bib59","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121081_bib60","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"issue":"27","key":"10.1016\/j.biomaterials.2021.121081_bib61","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/jcc.23702","article-title":"CHARMM-GUI Membrane Builder toward realistic biological membrane simulations","volume":"35","author":"Wu","year":"2014","journal-title":"J. Comput. Chem."},{"issue":"7","key":"10.1016\/j.biomaterials.2021.121081_bib62","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jcc.540150702","article-title":"New spherical-cutoff methods for long-range forces in macromolecular simulation","volume":"15","author":"Steinbach","year":"1994","journal-title":"J. Comput. Chem."},{"issue":"19","key":"10.1016\/j.biomaterials.2021.121081_bib63","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"issue":"8","key":"10.1016\/j.biomaterials.2021.121081_bib64","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"issue":"13","key":"10.1016\/j.biomaterials.2021.121081_bib65","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1073\/pnas.1502850112","article-title":"Immunomodulatory spherical nucleic acids","volume":"112","author":"Radovic-Moreno","year":"2015","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"11","key":"10.1016\/j.biomaterials.2021.121081_bib66","doi-asserted-by":"crossref","first-page":"8783","DOI":"10.1021\/nn202774x","article-title":"Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides","volume":"5","author":"Li","year":"2011","journal-title":"ACS Nano"},{"issue":"12","key":"10.1016\/j.biomaterials.2021.121081_bib67","doi-asserted-by":"crossref","first-page":"9696","DOI":"10.1021\/nn203161y","article-title":"Cellular immunostimulation by CpG-sequence-coated DNA origami structures","volume":"5","author":"Sch\u00fcller","year":"2011","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2021.121081_bib68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biomaterials.2017.11.021","article-title":"Rational incorporation of molecular adjuvants into a hybrid nanoparticle-based nicotine vaccine for immunotherapy against nicotine addiction","volume":"155","author":"Zhao","year":"2018","journal-title":"Biomaterials"},{"issue":"5","key":"10.1016\/j.biomaterials.2021.121081_bib69","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1189\/jlb.71.5.813","article-title":"Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide","volume":"71","author":"G\u00fcrsel","year":"2002","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib70","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1365-2567.2002.01410.x","article-title":"Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo","volume":"106","author":"Dalpke","year":"2002","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121081_bib71","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1089\/nat.2018.0761","article-title":"G-quadruplex structure improves the immunostimulatory effects of CpG oligonucleotides","volume":"29","author":"Kazuaki Hoshi","year":"2019","journal-title":"Nucleic Acid Therapeut."},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib72","doi-asserted-by":"crossref","first-page":"16673","DOI":"10.1038\/srep16673","article-title":"Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD","volume":"5","author":"Zhou","year":"2015","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.biomaterials.2021.121081_bib73","doi-asserted-by":"crossref","first-page":"7834","DOI":"10.1021\/ja101444j","article-title":"Virus-like particles templated by DNA micelles: a general method for loading virus nanocarriers","volume":"132","author":"Kwak","year":"2010","journal-title":"J. Am. Chem. Soc."},{"issue":"36","key":"10.1016\/j.biomaterials.2021.121081_bib74","doi-asserted-by":"crossref","first-page":"7271","DOI":"10.1039\/C8SC01771A","article-title":"Performing DNA nanotechnology operations on a zebrafish","volume":"9","author":"Yang","year":"2018","journal-title":"Chem. Sci."},{"issue":"10","key":"10.1016\/j.biomaterials.2021.121081_bib75","doi-asserted-by":"crossref","first-page":"1900043","DOI":"10.1002\/advs.201900043","article-title":"DNA nanotechnology enters cell membranes","volume":"6","author":"Huo","year":"2019","journal-title":"Adv. Sci."},{"issue":"14","key":"10.1016\/j.biomaterials.2021.121081_bib76","doi-asserted-by":"crossref","first-page":"1900389","DOI":"10.1002\/adhm.201900389","article-title":"Fast, efficient, and targeted liposome delivery mediated by DNA hybridization","volume":"8","author":"Li","year":"2019","journal-title":"Adv. Healthcare Mater."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121081_bib77","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1006\/abio.1997.2177","article-title":"Characterization of PicoGreen reagent and development of a fluorescence-based solution assay for double-stranded DNA quantitation","volume":"249","author":"Singer","year":"1997","journal-title":"Anal. Biochem."},{"issue":"13","key":"10.1016\/j.biomaterials.2021.121081_bib78","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/nar\/24.13.2623","article-title":"PicoGreen quantitation of DNA: effective evaluation of samples pre-or psost-PCR","volume":"24","author":"Ahn","year":"1996","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121081_bib79","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.it.2017.10.002","article-title":"Improving vaccine and immunotherapy design using biomaterials","volume":"39","author":"Bookstaver","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.biomaterials.2021.121081_bib80","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.nantod.2019.03.001","article-title":"DNA nanostructures in vitro, in vivo and on membranes","volume":"26","author":"Bae","year":"2019","journal-title":"Nano Today"},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121081_bib81","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/nn305030g","article-title":"Nuclease-resistant DNA via high-density packing in polymeric micellar nanoparticle coronas","volume":"7","author":"Rush","year":"2013","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121081_bib82","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20020773","article-title":"Potential role of phosphatidylinositol 3 kinase, rather than DNA-dependent protein kinase, in CpG DNA\u2013induced immune activation","volume":"196","author":"Ishii","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2021.121081_bib83","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-981-13-1435-3_12","article-title":"NF-kB and inflammatory cytokine signalling: role in skeletal muscle atrophy","volume":"1088","author":"Thoma","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.biomaterials.2021.121081_bib84","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1515\/revneuro-2011-068","article-title":"Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination","volume":"23","author":"Loda","year":"2012","journal-title":"Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121081_bib85","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/09680519040100040901","article-title":"Interferon response induced by Toll-like receptor signaling","volume":"10","author":"Takeuchi","year":"2004","journal-title":"J. Endotoxin Res."},{"issue":"27","key":"10.1016\/j.biomaterials.2021.121081_bib86","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1073\/pnas.0403744101","article-title":"CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells","volume":"101","author":"Sivori","year":"2004","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"3","key":"10.1016\/j.biomaterials.2021.121081_bib87","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/13543784.2020.1709822","article-title":"Phase I\/II parallel double-blind randomized controlled clinical trial of perispinal etanercept for chronic stroke: improved mobility and pain alleviation","volume":"29","author":"Ralph","year":"2020","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.biomaterials.2021.121081_bib88","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/biof.6","article-title":"Interferons and viral infections","volume":"35","author":"Fensterl","year":"2009","journal-title":"Biofactors"},{"issue":"6","key":"10.1016\/j.biomaterials.2021.121081_bib89","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.coviro.2011.10.008","article-title":"Interferon-stimulated genes and their antiviral effector functions","volume":"1","author":"Schoggins","year":"2011","journal-title":"Curr. Opin. Virol."},{"issue":"4","key":"10.1016\/j.biomaterials.2021.121081_bib90","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1586\/erv.10.174","article-title":"CpG DNA as a vaccine adjuvant","volume":"10","author":"Bode","year":"2011","journal-title":"Expert Rev. Vaccines"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221004373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961221004373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:02:59Z","timestamp":1758906179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961221004373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":90,"alternative-id":["S0142961221004373"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121081","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carrier-free micellar CpG interacting with cell membrane for enhanced immunological treatment of HIV-1","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2021.121081","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121081"}}